D. Western Therapeutics Institute, Inc.
Notice of Completion of Payment for Issuance of the 14th Stock Acquisition Rights (with Exercise Price Adjustment Clause) by Third-Party Allotment and Issuance of the 2nd Unsecured Corporate Bonds
Announced issuance of stock acquisition rights and completion of issuance/payment for unsecured corporate bonds. Total issuance amounts are 14,430,000 yen for the stock acquisition rights and 500,000,000 yen for the bonds. Allottees include Growth Capital and others; details are provided on exercise price adjustment conditions, lock-up, and memorandum agreements.
Key Figures
- Total amount of stock acquisition rights issued: 14,430,000 yen
- Total amount of these corporate bonds: 500,000,000 yen
- Number of potential shares: 39,000,000 shares
AI要約
Overview of Capital Policy
This announcement reports the issuance of the 14th stock acquisition rights by third-party allotment and the issuance/payment completion of the 2nd unsecured corporate bonds. The stock acquisition rights total 390,000 units, with a total issuance amount of 14,430,000 yen and an expected number of potential shares of 39,000,000 shares. The exercise price is initially 79 yen and will be adjusted in linkage with the closing price, with a floor set so it does not fall below 44 yen. The bonds total 500,000,000 yen, have a maturity date of October 29, 2027, and the allottees are Growth Capital and Next Growth.
Future Schedule and Impact
The company has announced completion of issuance and payment, and will proceed with enforcement of lock-up and exercise conditions based on the allotment agreements and memoranda. The capital policy aims to raise funds and may result in dilution risk from potential shares. The materials do not describe any direct impact on specific earnings targets.
D. Western Therapeutics Institute, Inc.
Company overview · Stock price · Financial data · All IR
